Réjuve ®
Your Spine Rejuvenated!

The injectable device technology named Réjuve® is designed to rapidly reinforce and stabilize the intervertebral disc tissue in a way similar to the body’s own natural response to heal instability and degradation of the spinal disc.

Message From The CEO
Investment Opportunity
Recent Events

October 2019: ILS Receives ISO-13485 Certification

Certification seal - ISO 13485 (002).jpg

August 2019: ILS Expands Trials Down Under

March 2019: Trials Begin Down Under

March 2018: Reaching To Five Corners For Clinical Studies

August 2017: Turning Skeptics Into Believers

May 2017: Exciting New Data for Rejuve

January 2017: Rejuve- Begins Multi-Site Pivotal Study

October 2016: Rejuve- Eliminates Low Back Pain

August 2016: ILS- Continues To See Positive Clinical Results

August 2016: ILS- Excited About Early Patient Feedback

June 2015: Large-Animal Study Yields Positive Results For Lower Back Pain

December 2014: In Vivo Testing Continues To Yield Positive Results

Dr. Hedman Discusses Recent Clinical Data
Dr. Grider Discusses The Opportunity
Dr. Hedman Talks About Rejuve

October 2014: Rejuve Receives Class IIB Pre-Assessment from Notified Body

© 2018 by Intralink-Spine Inc.  Réjuveis a registered trademark of Intralink-Spine, Inc.

Attention: Réjuve™ is not available for sale in the US, Canada, or EU. Clinical studies are pending.

Privacy Statement
Copyright Statement and Terms of Use

  • home

  • Rejuve

  • Press Releases

  • Distributors

  • About Us

  • Contact US

  • More